Target therapy for metastatic breast cancer.

Author: AyadiMouna, BattiRim, ChraietNesrine, MezliniAmel, MokraniAmina, RachdiHaifa

Paper Details 
Original Abstract of the Article :
Breast cancer is the first cancer in women worldwide. Since the previous estimates of WHO in 2008, incidence is increasing and it is estimated that 30% of women will develop immediately a metastatic form. However, advances in molecular biology and the discovery of new therapies have extended signifi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/30430522

データ提供:米国国立医学図書館(NLM)

Target Therapy for Metastatic Breast Cancer: A Personalized Approach to Treatment

Metastatic breast cancer, a formidable foe, can feel like an endless desert of uncertainty and fear. This research highlights the significant advancements in targeted therapies, offering personalized treatment options for patients with this complex disease.

The authors delve into the world of targeted therapies, exploring their mechanisms of action and effectiveness in treating metastatic breast cancer. They emphasize the importance of molecular profiling, which helps identify specific genetic and protein alterations that drive the growth and spread of the disease. By understanding the unique characteristics of each patient's tumor, physicians can tailor treatment plans to target these specific vulnerabilities, potentially improving treatment outcomes and extending survival.

Precision Medicine: A Beacon of Hope in the Desert of Cancer

This research highlights the promise of precision medicine, offering personalized treatment approaches that can revolutionize cancer care. The authors emphasize the importance of molecular profiling, which allows physicians to identify specific vulnerabilities in each patient's tumor, guiding the selection of targeted therapies that can effectively combat the disease.

Embracing Targeted Therapies: A New Era in Cancer Treatment

The fight against metastatic breast cancer is a difficult journey, but this research offers a ray of hope in the desert of uncertainty. The authors emphasize the transformative potential of targeted therapies, which can effectively target the specific vulnerabilities of each patient's tumor, potentially improving outcomes and extending survival.

Dr. Camel's Conclusion

This research offers a glimpse into the future of cancer treatment, where precision medicine takes center stage. The authors' findings highlight the power of targeted therapies, which can effectively combat the specific vulnerabilities of each patient's tumor, potentially improving outcomes and extending survival. This research serves as a beacon of hope, reminding us that the fight against cancer is constantly evolving, offering new avenues for treatment and a renewed sense of optimism.

Date :
  1. Date Completed 2019-09-24
  2. Date Revised 2019-09-25
Further Info :

Pubmed ID

30430522

DOI: Digital Object Identifier

/article-medicale-tunisie.php?article=3426

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.